Phase 2, Open-Label, Trial Evaluating Safety, Tolerability, and Preliminary Antitumor Activity of Panobinostat and Fractionated Stereotactic Reirradiation Therapy for Recurrent High-Grade Gliomas

Authors

Christopher Farrell

Publication/Presentation Date

11-2015

Volume

93

Issue

1

First Page

109

Last Page

110

Published In/Presented At

https://doi.org/10.1016/j.ijrobp.2015.07.262

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article